Capital Advisors Ltd’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
89
| – | – | ﹤0.01% | 1621 |
|
|
2025
Q1 | $0 | Sell |
89
-94
| -51% | – | ﹤0.01% | 1574 |
|
|
2024
Q4 | $1K | Hold |
183
| – | – | ﹤0.01% | 1303 |
|
|
2024
Q3 | $2K | Hold |
183
| – | – | ﹤0.01% | 1106 |
|
|
2024
Q2 | $1K | Hold |
183
| – | – | ﹤0.01% | 1296 |
|
|
2024
Q1 | $1K | Hold |
183
| – | – | ﹤0.01% | 1272 |
|
|
2023
Q4 | $1K | Hold |
183
| – | – | ﹤0.01% | 1225 |
|
|
2023
Q3 | $1K | Sell |
183
-5
| -3% | -$27 | ﹤0.01% | 1217 |
|
|
2023
Q2 | $2K | Hold |
188
| – | – | ﹤0.01% | 1049 |
|
|
2023
Q1 | $2K | Hold |
188
| – | – | ﹤0.01% | 939 |
|
|
2022
Q4 | $2K | Sell |
188
-12
| -6% | -$128 | ﹤0.01% | 903 |
|
|
2022
Q3 | $1K | Buy |
200
+98
| +96% | +$490 | ﹤0.01% | 1127 |
|
|
2022
Q2 | $0 | Buy |
+102
| New | – | ﹤0.01% | 1314 |
|